Document Classification

Section Type: RESULTS

Text: Baseline demographic characteristics were well balanced across the 4 treatment groups (mean [SD] age, 59. 7 [6. 4] years in the placebo group, 60. 8 [9. 2] years in the 0. 5 mg group, 60. 2 [6. 4] years in the 2. 5 mg group, and 59. 1 [8. 6] years in the 10 mg group ; mean [SD] weight, 67. 2 [10. 0] kg in the placebo group, 64. 5 [9. 0] kg in the 0. 5 mg group, 69. 6 [9. 4] kg in the 2. 5 mg group, and 63. 5 [12. 2] kg in the 10 mg group ; mean [SD] duration of T2DM diagnosis, 5. 1 [4. 2] years in the placebo group, 5. 2 [4. 7] years in the 0. 5 mg group, 5. 9 [4. 8] years in the 2. 5 mg group, and 2. 6 [2. 3] years in the 10 mg group).